$236.00
Manufacturer: UK
Description
Intravenous use of the drug is indicated for adults and children, including newborns, for the treatment of severe infections caused by certain aerobic gram-negative pathogens, in patients with limited treatment options.
The drug in the form of inhalations is also indicated for adults and children with cystic fibrosis for the treatment of chronic lung infections caused by Pseudomonas aeruginosa.
Official recommendations for the proper use of antibacterial agents should be followed.
Recent Reviews